ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Fractionation Market Research Report 2026
Published Date: 2026-01-16
|
Report Code: QYRE-Auto-4176
Home | Market Reports
Global Plasma Fractionation Market Insights and Forecast to 2028
BUY CHAPTERS

Global Plasma Fractionation Market Research Report 2026

Code: QYRE-Auto-4176
Report
2026-01-16
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Grifols
Grifols S A
Octapharma AG
Takeda
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Plasma Fractionation Market Size

The global Plasma Fractionation market was valued at US$ 37710 million in 2025 and is anticipated to reach US$ 62130 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Plasma Fractionation Market

Plasma Fractionation Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.
North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.
This report delivers a comprehensive overview of the global Plasma Fractionation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma Fractionation. The Plasma Fractionation market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Plasma Fractionation market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Plasma Fractionation manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Plasma Fractionation Market Report

Report Metric Details
Report Name Plasma Fractionation Market
Accounted market size in 2025 US$ 37710 million
Forecasted market size in 2032 US$ 62130 million
CAGR 7.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Plasma Fractionation companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Plasma Fractionation Market growing?

Ans: The Plasma Fractionation Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Plasma Fractionation Market size in 2032?

Ans: The Plasma Fractionation Market size in 2032 will be US$ 62130 million.

What is the Plasma Fractionation Market share by type?

Ans: In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.

What is the Plasma Fractionation Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40 % in 2023.

Who are the main players in the Plasma Fractionation Market report?

Ans: The main players in the Plasma Fractionation Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Plasma Fractionation Market report?

Ans: The Applications covered in the Plasma Fractionation Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Plasma Fractionation Market report?

Ans: The Types covered in the Plasma Fractionation Market report are Albumin, Immune Globulin, Coagulation Factor, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fractionation Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Fractionation Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Fractionation Market Perspective (2021–2032)
2.2 Global Plasma Fractionation Growth Trends by Region
2.2.1 Global Plasma Fractionation Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Plasma Fractionation Historic Market Size by Region (2021–2026)
2.2.3 Plasma Fractionation Forecasted Market Size by Region (2027–2032)
2.3 Plasma Fractionation Market Dynamics
2.3.1 Plasma Fractionation Industry Trends
2.3.2 Plasma Fractionation Market Drivers
2.3.3 Plasma Fractionation Market Challenges
2.3.4 Plasma Fractionation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Fractionation Players by Revenue
3.1.1 Global Top Plasma Fractionation Players by Revenue (2021–2026)
3.1.2 Global Plasma Fractionation Revenue Market Share by Players (2021–2026)
3.2 Global Top Plasma Fractionation Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Plasma Fractionation Revenue
3.4 Global Plasma Fractionation Market Concentration Ratio
3.4.1 Global Plasma Fractionation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fractionation Revenue in 2025
3.5 Global Key Players of Plasma Fractionation Head Offices and Areas Served
3.6 Global Key Players of Plasma Fractionation, Products and Applications
3.7 Global Key Players of Plasma Fractionation, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Plasma Fractionation Breakdown Data by Type
4.1 Global Plasma Fractionation Historic Market Size by Type (2021–2026)
4.2 Global Plasma Fractionation Forecasted Market Size by Type (2027–2032)
5 Plasma Fractionation Breakdown Data by Application
5.1 Global Plasma Fractionation Historic Market Size by Application (2021–2026)
5.2 Global Plasma Fractionation Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Plasma Fractionation Market Size (2021–2032)
6.2 North America Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Plasma Fractionation Market Size by Country (2021–2026)
6.4 North America Plasma Fractionation Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Fractionation Market Size (2021–2032)
7.2 Europe Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Plasma Fractionation Market Size by Country (2021–2026)
7.4 Europe Plasma Fractionation Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fractionation Market Size (2021–2032)
8.2 Asia-Pacific Plasma Fractionation Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Plasma Fractionation Market Size by Region (2021–2026)
8.4 Asia-Pacific Plasma Fractionation Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Plasma Fractionation Market Size (2021–2032)
9.2 Latin America Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Plasma Fractionation Market Size by Country (2021–2026)
9.4 Latin America Plasma Fractionation Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fractionation Market Size (2021–2032)
10.2 Middle East & Africa Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Plasma Fractionation Market Size by Country (2021–2026)
10.4 Middle East & Africa Plasma Fractionation Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Fractionation Introduction
11.1.4 Takeda Revenue in Plasma Fractionation Business (2021–2026)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Fractionation Introduction
11.2.4 CSL Revenue in Plasma Fractionation Business (2021–2026)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma Fractionation Introduction
11.3.4 Grifols Revenue in Plasma Fractionation Business (2021–2026)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma Fractionation Introduction
11.4.4 Octapharma Revenue in Plasma Fractionation Business (2021–2026)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma Fractionation Introduction
11.5.4 Kedrion Revenue in Plasma Fractionation Business (2021–2026)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma Fractionation Introduction
11.6.4 LFB Group Revenue in Plasma Fractionation Business (2021–2026)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma Fractionation Introduction
11.7.4 Biotest Revenue in Plasma Fractionation Business (2021–2026)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Plasma Fractionation Introduction
11.8.4 BPL Revenue in Plasma Fractionation Business (2021–2026)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma Fractionation Introduction
11.9.4 RAAS Revenue in Plasma Fractionation Business (2021–2026)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma Fractionation Introduction
11.10.4 CBPO Revenue in Plasma Fractionation Business (2021–2026)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma Fractionation Introduction
11.11.4 Hualan Bio Revenue in Plasma Fractionation Business (2021–2026)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Plasma Fractionation Introduction
11.12.4 Tiantan Bio Revenue in Plasma Fractionation Business (2021–2026)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Plasma Fractionation Introduction
11.13.4 Shuanglin Bio Revenue in Plasma Fractionation Business (2021–2026)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Plasma Fractionation Introduction
11.14.4 Boya Bio Revenue in Plasma Fractionation Business (2021–2026)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Plasma Fractionation Introduction
11.15.4 Yuanda Shuyang Revenue in Plasma Fractionation Business (2021–2026)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Plasma Fractionation Introduction
11.16.4 Weiguang Bio Revenue in Plasma Fractionation Business (2021–2026)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Plasma Fractionation Introduction
11.17.4 Nanyue Bio Revenue in Plasma Fractionation Business (2021–2026)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Plasma Fractionation Introduction
11.18.4 KM Biologics Revenue in Plasma Fractionation Business (2021–2026)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
CSL Limited
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Grifols
Grifols S A
Octapharma AG
Takeda
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
List of Tables
 Table 1. Global Plasma Fractionation Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Albumin
 Table 3. Key Players of Immune Globulin
 Table 4. Key Players of Coagulation Factor
 Table 5. Key Players of Others
 Table 6. Global Plasma Fractionation Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Plasma Fractionation Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Plasma Fractionation Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Plasma Fractionation Market Share by Region (2021–2026)
 Table 10. Global Plasma Fractionation Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Plasma Fractionation Market Share by Region (2027–2032)
 Table 12. Plasma Fractionation Market Trends
 Table 13. Plasma Fractionation Market Drivers
 Table 14. Plasma Fractionation Market Challenges
 Table 15. Plasma Fractionation Market Restraints
 Table 16. Global Plasma Fractionation Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Plasma Fractionation Market Share by Players (2021–2026)
 Table 18. Global Top Plasma Fractionation Players by Tier (Tier 1, Tier 2, and Tier 3), based on Plasma Fractionation Revenue, 2025
 Table 19. Ranking of Global Top Plasma Fractionation Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Plasma Fractionation Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Plasma Fractionation, Headquarters and Area Served
 Table 22. Global Key Players of Plasma Fractionation, Products and Applications
 Table 23. Global Key Players of Plasma Fractionation, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Plasma Fractionation Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Plasma Fractionation Revenue Market Share by Type (2021–2026)
 Table 27. Global Plasma Fractionation Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Plasma Fractionation Revenue Market Share by Type (2027–2032)
 Table 29. Global Plasma Fractionation Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Plasma Fractionation Revenue Market Share by Application (2021–2026)
 Table 31. Global Plasma Fractionation Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Plasma Fractionation Revenue Market Share by Application (2027–2032)
 Table 33. North America Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Plasma Fractionation Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Plasma Fractionation Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Plasma Fractionation Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Plasma Fractionation Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Plasma Fractionation Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Plasma Fractionation Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Plasma Fractionation Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Plasma Fractionation Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Plasma Fractionation Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Plasma Fractionation Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Plasma Fractionation Market Size by Country (US$ Million), 2027–2032
 Table 48. Takeda Company Details
 Table 49. Takeda Business Overview
 Table 50. Takeda Plasma Fractionation Product
 Table 51. Takeda Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 52. Takeda Recent Development
 Table 53. CSL Company Details
 Table 54. CSL Business Overview
 Table 55. CSL Plasma Fractionation Product
 Table 56. CSL Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 57. CSL Recent Development
 Table 58. Grifols Company Details
 Table 59. Grifols Business Overview
 Table 60. Grifols Plasma Fractionation Product
 Table 61. Grifols Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 62. Grifols Recent Development
 Table 63. Octapharma Company Details
 Table 64. Octapharma Business Overview
 Table 65. Octapharma Plasma Fractionation Product
 Table 66. Octapharma Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 67. Octapharma Recent Development
 Table 68. Kedrion Company Details
 Table 69. Kedrion Business Overview
 Table 70. Kedrion Plasma Fractionation Product
 Table 71. Kedrion Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 72. Kedrion Recent Development
 Table 73. LFB Group Company Details
 Table 74. LFB Group Business Overview
 Table 75. LFB Group Plasma Fractionation Product
 Table 76. LFB Group Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 77. LFB Group Recent Development
 Table 78. Biotest Company Details
 Table 79. Biotest Business Overview
 Table 80. Biotest Plasma Fractionation Product
 Table 81. Biotest Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 82. Biotest Recent Development
 Table 83. BPL Company Details
 Table 84. BPL Business Overview
 Table 85. BPL Plasma Fractionation Product
 Table 86. BPL Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 87. BPL Recent Development
 Table 88. RAAS Company Details
 Table 89. RAAS Business Overview
 Table 90. RAAS Plasma Fractionation Product
 Table 91. RAAS Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 92. RAAS Recent Development
 Table 93. CBPO Company Details
 Table 94. CBPO Business Overview
 Table 95. CBPO Plasma Fractionation Product
 Table 96. CBPO Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 97. CBPO Recent Development
 Table 98. Hualan Bio Company Details
 Table 99. Hualan Bio Business Overview
 Table 100. Hualan Bio Plasma Fractionation Product
 Table 101. Hualan Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 102. Hualan Bio Recent Development
 Table 103. Tiantan Bio Company Details
 Table 104. Tiantan Bio Business Overview
 Table 105. Tiantan Bio Plasma Fractionation Product
 Table 106. Tiantan Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 107. Tiantan Bio Recent Development
 Table 108. Shuanglin Bio Company Details
 Table 109. Shuanglin Bio Business Overview
 Table 110. Shuanglin Bio Plasma Fractionation Product
 Table 111. Shuanglin Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 112. Shuanglin Bio Recent Development
 Table 113. Boya Bio Company Details
 Table 114. Boya Bio Business Overview
 Table 115. Boya Bio Plasma Fractionation Product
 Table 116. Boya Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 117. Boya Bio Recent Development
 Table 118. Yuanda Shuyang Company Details
 Table 119. Yuanda Shuyang Business Overview
 Table 120. Yuanda Shuyang Plasma Fractionation Product
 Table 121. Yuanda Shuyang Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 122. Yuanda Shuyang Recent Development
 Table 123. Weiguang Bio Company Details
 Table 124. Weiguang Bio Business Overview
 Table 125. Weiguang Bio Plasma Fractionation Product
 Table 126. Weiguang Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 127. Weiguang Bio Recent Development
 Table 128. Nanyue Bio Company Details
 Table 129. Nanyue Bio Business Overview
 Table 130. Nanyue Bio Plasma Fractionation Product
 Table 131. Nanyue Bio Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 132. Nanyue Bio Recent Development
 Table 133. KM Biologics Company Details
 Table 134. KM Biologics Business Overview
 Table 135. KM Biologics Plasma Fractionation Product
 Table 136. KM Biologics Revenue in Plasma Fractionation Business (US$ Million), 2021–2026
 Table 137. KM Biologics Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Plasma Fractionation Picture
 Figure 2. Global Plasma Fractionation Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Plasma Fractionation Market Share by Type: 2025 vs 2032
 Figure 4. Albumin Features
 Figure 5. Immune Globulin Features
 Figure 6. Coagulation Factor Features
 Figure 7. Others Features
 Figure 8. Global Plasma Fractionation Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Plasma Fractionation Market Share by Application: 2025 vs 2032
 Figure 10. Hospital Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Other Case Studies
 Figure 13. Plasma Fractionation Report Years Considered
 Figure 14. Global Plasma Fractionation Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Plasma Fractionation Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Plasma Fractionation Market Share by Region: 2025 vs 2032
 Figure 17. Global Plasma Fractionation Market Share by Players in 2025
 Figure 18. Global Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Plasma Fractionation Revenue in 2025
 Figure 20. North America Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Plasma Fractionation Market Share by Country (2021–2032)
 Figure 22. United States Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Plasma Fractionation Market Share by Country (2021–2032)
 Figure 26. Germany Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Plasma Fractionation Market Share by Region (2021–2032)
 Figure 34. China Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Plasma Fractionation Market Share by Country (2021–2032)
 Figure 42. Mexico Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Plasma Fractionation Market Share by Country (2021–2032)
 Figure 46. Israel Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Takeda Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 50. CSL Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 51. Grifols Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 52. Octapharma Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 53. Kedrion Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 54. LFB Group Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 55. Biotest Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 56. BPL Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 57. RAAS Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 58. CBPO Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 59. Hualan Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 60. Tiantan Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 61. Shuanglin Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 62. Boya Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 63. Yuanda Shuyang Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 64. Weiguang Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 65. Nanyue Bio Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 66. KM Biologics Revenue Growth Rate in Plasma Fractionation Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Blood Plasma Fractionation Market Research Report 2025
Global Plasma Fractionation Technology Market Research Report 2025
Global Blood Plasma Fractionation Technology Market Research Report 2025
Global Human Plasma Fractionation Product Market Research Report 2024
Global Human Blood Plasma Fractionation Market Research Report 2025
Plasma Fractionation and Blood Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Fractionation Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fractionated Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma for Fractionation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Protein Products Market Research Report 2024
Global Plasma derived Medical Product Market Research Report 2025
Human Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Biological Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Product Market Insights Forecast to 2030
Global Plasma Protein Therapeutics Market Research Report 2025
Global Blood Plasma Fractionators Market Research Report 2025
Plasma Processing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Banking and Blood Products Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions